huperzine A

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







82 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35630613 Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors. 2022 May 13 1
2 33930191 Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget. 2021 Sep 1
3 34156230 Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease. 2021 Jul 7 1
4 34363318 Structural Fractal Analysis of the Active Site of Acetylcholinesterase in Complexes with Huperzine A, Galantamine, and Donepezil. 2021 Nov 1
5 34445873 Pd-Catalyzed Direct Diversification of Natural Anti-Alzheimer's Disease Drug: Synthesis and Biological Evaluation of N-Aryl Huperzine A Analogues. 2021 Aug 27 1
6 34966281 Integration of System Biology Tools to Investigate Huperzine A as an Anti-Alzheimer Agent. 2021 2
7 32712274 Slow-binding inhibitors of acetylcholinesterase of medical interest. 2020 Oct 15 1
8 33327436 The Cholinesterase Inhibitory Properties of Stephaniae Tetrandrae Radix. 2020 Dec 14 1
9 30101703 Phytoconstituents and their Possible Mechanistic Profile for Alzheimer's Disease - A Literature Review. 2019 1
10 31575200 Frequency domain modeling of quasielastic neutron scattering from hydrated protein powders: Application to free and inhibited human acetylcholinesterase. 2019 Sep 28 1
11 31847089 Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex. 2019 Dec 13 2
12 29670172 Acetylcholine and necroptosis are players in follicular development in primates. 2018 Apr 18 1
13 27900576 Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques. 2017 Jul 4
14 28110700 Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease. 2017 Feb 4
15 28788095 Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. 2017 Jul 28 2
16 29058298 Pharmacokinetics and tolerability of oral dosage forms of huperzine a in healthy Chinese male volunteers: a randomized, single dose, three-period, six-sequence crossover study. 2017 Oct 1
17 26902639 Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer's disease. 2016 Apr 5 2
18 27605862 Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials. 2016 Apr 25 2
19 25766324 Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions? 2015 Mar 12 1
20 25875590 Development of ESI-MS-based continuous enzymatic assay for real-time monitoring of enzymatic reactions of acetylcholinesterase. 2015 May 15 2
21 26364275 Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. 2015 Sep 12 2
22 24059299 Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach. 2014 Apr 5
23 24611490 A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study. 2014 Aug 1
24 24872501 Correlation of the dynamics of native human acetylcholinesterase and its inhibited huperzine A counterpart from sub-picoseconds to nanoseconds. 2014 Aug 6 2
25 24890706 Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors. 2014 Aug 1
26 23085120 Bis(12)-hupyridone, a novel acetylcholinesterase inhibitor, protects against glutamate-induced neuronal excitotoxicity via activating α7 nicotinic acetylcholine receptor/phosphoinositide 3-kinase/Akt cascade. 2013 Mar 25 2
27 23229229 In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile. 2013 Mar 2
28 23273608 Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. 2013 Feb 1 4
29 23399701 Huperzine A, but not tacrine, stimulates S100B secretion in astrocyte cultures. 2013 Apr 9 2
30 23440190 Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. 2013 Mar 12 3
31 22932810 On-line immobilized acetylcholinesterase microreactor for screening of inhibitors from natural extracts by capillary electrophoresis. 2012 Nov 1
32 22941287 New insights into huperzine A for the treatment of Alzheimer's disease. 2012 Sep 2
33 23186408 Energy landscapes of human acetylcholinesterase and its Huperzine A-inhibited counterpart. 2012 Dec 27 2
34 20851778 Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method. 2011 Feb 2
35 21185313 The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques. 2011 Jun 2
36 20452337 Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. 2010 Sep 6 2
37 20737911 Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius. 2010 Jul-Aug 1
38 21052939 Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors. 2010 Oct 1
39 19110209 Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets. 2009 Jan 1
40 19221692 Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. 2009 Apr 1
41 19622237 Green tea polyphenol (-)-epigallocatechin-3-gallate enhances the inhibitory effect of huperzine A on acetylcholinesterase by increasing the affinity with serum albumin. 2009 Aug 1
42 19726199 Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives. 2009 Oct 1 3
43 17657601 Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. 2008 Feb 1
44 18555980 Comparison of methods used for the determination of cholinesterase activity in whole blood. 2008 Sep 25 1
45 18572153 Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. 2008 Sep 25 6
46 18789720 Monitoring enzyme reaction and screening of inhibitors of acetylcholinesterase by quantitative matrix-assisted laser desorption/ionization Fourier transform mass spectrometry. 2008 Dec 1
47 23480140 Huprines for Alzheimer's disease drug development. 2008 Jan 2
48 17080497 Simple determination of huperzine A in human plasma by liquid chromatographic-tandem mass spectrometric method. 2007 Jan 1
49 17097792 Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge. 2007 Apr 20 1
50 17945434 Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. 2007 Dec 5 1